Cargando…
Hypercalcaemia secondary to hypophysitis and cortisol deficiency: another immunotherapy-related adverse event
SUMMARY: Hypercalcaemia is a common complication seen in malignancy, frequently due to paraneoplastic parathyroid hormone-related peptide production or osteolytic bony metastases. We present a 58-year-old female with immunotherapy-mediated hypophysitis causing secondary cortisol deficiency resulting...
Autores principales: | Miller, Samuel R, Kumar, Shejil, Yuile, Alexander, Menzies, Alexander M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875066/ https://www.ncbi.nlm.nih.gov/pubmed/36648353 http://dx.doi.org/10.1530/EDM-22-0375 |
Ejemplares similares
-
Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
por: Nizar, Ryizan, et al.
Publicado: (2021) -
Complexities surrounding the diagnosis and management of hypercalcaemia in pregnancy
por: Rodrigo, Natassia, et al.
Publicado: (2021) -
An uncanny case of paraneoplastic calcitriol mediated hypercalcaemia
por: Shah, Preet Mukesh, et al.
Publicado: (2023) -
Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder
por: Ravindran, Ravikumar, et al.
Publicado: (2020) -
Glucocorticoid-induced adrenal insufficiency: an uncommon cause of hypercalcaemia
por: De Silva, S D N, et al.
Publicado: (2022)